Jump Financial, LLC Gossamer Bio, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.8 - $1.51 $115,959 - $218,872	144,949 New	144,949 $171,000
Q3 2022 Nov 07, 2022	BUY	$7.21 - $14.88 $199,717 - $412,176	27,700 New	27,700 $332,000
Q2 2022 Aug 09, 2022	SELL	$5.97 - $9.97 $211,935 - $353,935	-35,500 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$8.44 - $12.49 $106,073 - $156,974	-12,568 Reduced 26.15%	35,500 $308,000
Q4 2021 Feb 10, 2022	BUY	$10.12 - $14.07 $486,448 - $676,316	48,068 New	48,068 $544,000
Q2 2021 Aug 13, 2021	SELL	$8.0 - $9.75 $119,448 - $145,577	-14,931 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $128,854 - $163,345	14,931 New	14,931 $138,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.